Latest News About Vigamox Eye Drop

Here’s the latest I can share based on available public information up to now.

• Vigamox is a fluoroquinolone antibiotic eye drop (moxifloxacin 0.5%) used to treat bacterial conjunctivitis and certain other eye infections. It has been marketed in the U.S. under the Vigamox name since Harrow (and previously Novartis) work to transfer the NDA and commercial rights.[1][2]
• The US label outlines typical dosing as one drop in the affected eye three times daily for seven days, with common ocular side effects including conjunctivitis, decreased visual acuity, dry eye, keratitis, ocular discomfort, and redness, each occurring in roughly 1–6% of patients; nonocular adverse events occur in about 1–4% of patients (fever, cough, etc.).[3][4][6]
• Recent FDA DailyMed labeling confirms the 0.5% ophthalmic solution and the same dosing window, and provides the full safety profile and contraindications (hypersensitivity to moxifloxacin or other quinolones).[9][3]
• Industry coverage notes the U.S. commercial rights were acquired by Harrow in early 2023, with the NDA transfer completing and Vigamox becoming commercially available under the Harrow brand in 2023; reputable ophthalmology outlets have published on Harrow’s launch in the U.S. context.[2][1]

Key takeaways for patients in Dallas, TX:

• If you’ve been prescribed Vigamox, use exactly as directed: one drop in the affected eye three times daily for seven days, unless your clinician instructs otherwise.[3][9]
• Report any signs of allergy or severe adverse reactions, or if symptoms don’t improve within a few days, to your eye care provider.
• If you’re seeking the most current local availability or formulary status in your clinic, contact your ophthalmologist or pharmacist, as purchaser/brand status can vary by region and institution.

If you’d like, I can try to pull the most recent press releases or labeling updates and summarize any changes in dosing, safety, or indications. I can also help you find a local pharmacy or clinic in Dallas that stocks Vigamox.